IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Fredi, Micaela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.019
AS - Asia 2.712
EU - Europa 2.112
SA - Sud America 620
AF - Africa 64
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.910
SG - Singapore 1.008
CN - Cina 763
BR - Brasile 533
DE - Germania 411
HK - Hong Kong 373
IT - Italia 373
UA - Ucraina 372
VN - Vietnam 191
FI - Finlandia 190
GB - Regno Unito 170
RU - Federazione Russa 147
TR - Turchia 120
IE - Irlanda 106
FR - Francia 76
PL - Polonia 76
IN - India 68
CA - Canada 60
SE - Svezia 46
BD - Bangladesh 40
AR - Argentina 37
MX - Messico 33
ZA - Sudafrica 30
IQ - Iraq 23
AT - Austria 20
PK - Pakistan 19
ID - Indonesia 18
ES - Italia 17
NL - Olanda 17
JP - Giappone 15
BE - Belgio 14
EC - Ecuador 13
MA - Marocco 13
LT - Lituania 12
CZ - Repubblica Ceca 11
KE - Kenya 9
PY - Paraguay 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
SA - Arabia Saudita 8
AL - Albania 7
IL - Israele 7
KZ - Kazakistan 7
MK - Macedonia 7
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CL - Cile 5
CO - Colombia 5
GR - Grecia 5
JO - Giordania 5
NP - Nepal 5
PT - Portogallo 5
ET - Etiopia 4
PH - Filippine 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
HN - Honduras 3
KR - Corea 3
LV - Lettonia 3
MY - Malesia 3
NO - Norvegia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
LB - Libano 2
LU - Lussemburgo 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UG - Uganda 1
Totale 11.539
Salva come PNG Salva come JPEG
Città #
Fairfield 717
Ashburn 523
Woodbridge 481
Singapore 464
Hong Kong 372
Houston 300
Jacksonville 287
Cambridge 266
Seattle 238
Wilmington 231
Beijing 226
Chandler 219
Ann Arbor 213
Chicago 191
Los Angeles 174
Princeton 173
New York 161
Helsinki 138
Dublin 106
Istanbul 102
Dallas 86
Salt Lake City 81
Munich 76
Warsaw 73
The Dalles 70
Nanjing 69
Brescia 62
Ho Chi Minh City 58
Moscow 48
Redondo Beach 45
Buffalo 44
Hanoi 44
Shanghai 44
San Francisco 42
São Paulo 39
San Diego 36
Des Moines 34
London 33
Nanchang 32
Elk Grove Village 30
Nuremberg 29
Tampa 29
Turku 28
Lancaster 27
Shenyang 25
Changsha 24
Phoenix 23
Hebei 22
Montreal 21
Brooklyn 20
Johannesburg 20
Milan 20
Tianjin 19
Atlanta 18
Chennai 18
Romola 18
Santa Clara 18
Jiaxing 16
Rome 15
Tokyo 15
Brussels 14
Miami 14
Porto Alegre 13
Cagliari 12
Denver 12
Dong Ket 12
Jinan 12
Rio de Janeiro 12
Stockholm 12
Mexico City 11
Orem 11
Ottawa 11
Sterling 11
Vienna 11
Belo Horizonte 10
Brasília 10
Dearborn 10
Dulles 10
Frankfurt am Main 10
Hangzhou 10
Manchester 10
Nürnberg 10
Rozzano 10
Toronto 10
Dhaka 9
Falkenstein 9
Ningbo 9
Verona 9
Washington 9
Bergamo 8
Biên Hòa 8
Council Bluffs 8
Guangzhou 8
Haiphong 8
Jakarta 8
Pune 8
Querétaro 8
Campinas 7
Curitiba 7
Detroit 7
Totale 7.451
Salva come PNG Salva come JPEG
Nome #
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 683
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 212
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 211
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 184
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 174
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 167
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 167
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 167
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 165
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 163
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 161
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 154
Antiphospholipid antibodies mediate autoimmunity against dying cells. 154
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 153
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 153
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 153
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 151
The clinico-serological spectrum of overlap myositis 149
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 147
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 147
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 146
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 142
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 139
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 139
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 138
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 136
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 134
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 133
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 131
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 130
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 129
IRF5 is associated with primary antiphospholipid syndrome,but is not a major risk factor 128
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 127
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 127
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 119
Myositis autoantibodies and clinical phenotypes 118
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 118
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 116
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 116
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 116
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 114
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 109
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 109
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 109
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 109
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 108
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 108
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 107
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 105
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 104
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 103
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 103
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 102
ANTIPHOSPHOLIPID ANTIBODIES AND CEREBROVASCULAR EVENTS. WHICH FACTORS ASSOCIATE WITH ONSET AND RECURRENCE? - POSTER TOURS 99
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 97
Should we treat congenital heart block with fluorinated corticosteroids? 96
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 94
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis 93
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications 91
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 91
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 89
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 85
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry 84
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 83
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 83
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 81
Autoimmune polyglandular syndrome type 4: experience from a single reference center 79
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 78
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 76
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 75
Managing puerperium in patients with systemic autoimmune diseases: an update 72
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 71
Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study 70
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 70
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 67
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 66
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 64
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 64
Neutrophil Extracellular Traps in the Autoimmunity Context. 63
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis 61
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses 60
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 60
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 60
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 60
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 59
Association of Natural Killer Cell Ligand Polymorphism, HLAC Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block 57
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 57
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 55
Systemic lupus erythematosus: state of the art on clinical practice guidelines 55
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 53
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 53
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 52
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 51
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 50
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women 50
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 50
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 49
Editorial: Into the heart of systemic autoimmune diseases. 49
Topoisomerase I (SCL 70) Autoantibodies 49
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 45
Totale 11.003
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.723
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021879 0 0 0 0 0 189 52 139 120 185 95 99
2021/2022776 67 83 54 41 12 54 26 60 44 95 71 169
2022/2023752 102 7 9 43 74 208 11 90 126 7 35 40
2023/2024927 55 21 79 114 58 151 37 49 198 26 20 119
2024/20252.702 23 38 40 238 195 186 144 92 222 209 579 736
2025/20262.535 402 618 325 672 470 48 0 0 0 0 0 0
Totale 11.749